This study aimed to evaluate the predictive value of combining these inflammatory markers with tumor markers (CA125, HE4) and specific ultrasonographic features for the diagnosis of BOETs.<h4>Results</h4>The study enrolled 301 patients (101 benign, 99 BOETs, 101 malignant). The gene discussed is WFDC2; the disease is neoplasm.